Cargando…

Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer

BACKGROUND: Bilateral-Risk-Reducing-Mastectomy-(BRRM) is well described in BRCA1/2 pathogenic variant carriers. However, little is known about the relative uptake, time trends or factors influencing uptake in those at increased breast cancer risk not known to be carriers. The aim of this study is to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, D.Gareth, Gandhi, Ashu, Wisely, Julie, Clancy, Tara, Woodward, Emma R., Harvey, James, Highton, Lyndsey, Murphy, John, Barr, Lester, Howell, Sacha J., Lalloo, Fiona, Harkness, Elaine F., Howell, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406355/ https://www.ncbi.nlm.nih.gov/pubmed/34464846 http://dx.doi.org/10.1016/j.breast.2021.08.015

Ejemplares similares

Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
por: Evans, D. Gareth, et al.
Publicado: (2015)

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
por: Basu, Narendra Nath, et al.
Publicado: (2021)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020)
por: Howell, Anthony, et al.
Publicado: (2020)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores
por: Evans, D. G., et al.
Publicado: (2016)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021)

Draft Genome Sequences of Two Yersinia pseudotuberculosis ST43 (O:1b) Strains, B-7194 and B-7195
por: Blouin, Yann, et al.
Publicado: (2013)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
por: Woodward, Emma R., et al.
Publicado: (2021)

Increased risk of breast cancer in neurofibromatosis type 1: current insights
por: Howell, Sacha J, et al.
Publicado: (2017)

30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes
por: Woodward, Emma R., et al.
Publicado: (2021)

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Bilateral risk-reducing mastectomies in American culture
por: Pearl, Sharrona
Publicado: (2023)

Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting
por: McWilliams, Lorna, et al.
Publicado: (2022)

The Manchester guidelines for contralateral risk-reducing mastectomy
por: Basu, Narendra Nath, et al.
Publicado: (2015)

Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies
por: Basu, N. N., et al.
Publicado: (2015)

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester
por: Pegington, Mary, et al.
Publicado: (2023)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
por: Prosperi, Mattia CF, et al.
Publicado: (2014)

Breast cancer risk-assessment models
por: Evans, D Gareth R, et al.
Publicado: (2007)

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program
por: Wright, Stuart J., et al.
Publicado: (2023)

Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
por: Maeshima, Yurina, et al.
Publicado: (2016)

Can the breast screening appointment be used to provide risk assessment and prevention advice?
por: Evans, D. Gareth, et al.
Publicado: (2015)

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT
por: Challberg, J, et al.
Publicado: (2011)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Abstract: Contralateral Prophylactic Mastectomy: The Argument for Bilateral Mastectomies and Reconstruction
por: Schultz, Benjamin D., et al.
Publicado: (2018)

The Role of Bilateral Prophylactic Mastectomy (BPMX) in Women at High Risk of Breast Cancer
por: Baildam, A. D.
Publicado: (1999)

Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers
por: Glassey, Rachael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6qocos396fcamf9385hjrjiqi6